Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1231 AL 1245

HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer's disease

Albaret MA, Textoris J, Dalzon B, Lambert J, Linard M, Helmer C, Hacot S, Ghayad SE, Ferréol M, Mertani HC, Diaz JJ.

Transl Psychiatry. 2023 Mar 10;13(1):86. doi: 10.1038/s41398-023-02376-8.

Using Optogenetics to Model Cellular Effects of Alzheimer's Disease

Tiwari P, Tolwinski NS.

Int J Mol Sci. 2023 Feb 21;24(5):4300. doi: 10.3390/ijms24054300.

Aducanumab-Hope or Disappointment for Alzheimer's Disease

Wojtunik-Kulesza K, Rudkowska M, Orzeł-Sajdłowska A.

Int J Mol Sci. 2023 Feb 22;24(5):4367. doi: 10.3390/ijms24054367.

Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease

Vrabec R, Blunden G, Cahlíková L.

Int J Mol Sci. 2023 Feb 23;24(5):4399. doi: 10.3390/ijms24054399.

The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease

Richter E, Geetha T, Burnett D, Broderick TL, Babu JR.

Int J Mol Sci. 2023 Feb 28;24(5):4643. doi: 10.3390/ijms24054643.

Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?

Yin C, Harms AC, Hankemeier T, Kindt A, de Lange ECM.

Int J Mol Sci. 2023 Mar 4;24(5):4960. doi: 10.3390/ijms24054960.

Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease

Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, Geng F.

Molecules. 2023 Mar 3;28(5):2336. doi: 10.3390/molecules28052336.

Oxidative stress: A target to treat Alzheimer's disease and stroke

Briyal S, Ranjan AK, Gulati A.

Neurochem Int. 2023 May;165:105509. doi: 10.1016/j.neuint.2023.105509. Epub 2023 Mar 11.

[Lecanemab in Alzheimer's disease: are we really before a shift in the prognosis of the disease?]

Pérez-Martínez DA.

Rev Neurol. 2023 Mar 16;76(6):185-188. doi: 10.33588/rn.7606.2023055.

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease

Karamacoska D, Chan DKY, Leung I, Liu JX, Brodaty H, Fahey PP, Bensoussan A, Chang DH.

PLoS One. 2023 Mar 15;18(3):e0265285. doi: 10.1371/journal.pone.0265285. eCollection 2023.

Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease

Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Chu J, Liang W, Gao J, Yin Y.

Theranostics. 2023 Feb 5;13(4):1264-1285. doi: 10.7150/thno.81860. eCollection 2023.

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects

Sharma P, Singh M.

Life Sci. 2023 May 1;320:121568. doi: 10.1016/j.lfs.2023.121568. Epub 2023 Mar 15.

Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases

Marsool MDM, Prajjwal P, Reddy YB, Marsool ADM, Lam JR, Nandwana V.

Dis Mon. 2023 May;69(5):101547. doi: 10.1016/j.disamonth.2023.101547. Epub 2023 Mar 15.

Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer's disease

Dubey S, Singh E.

Inflammopharmacology. 2023 Apr;31(2):717-730. doi: 10.1007/s10787-023-01173-5. Epub 2023 Mar 18.

The effectiveness and safety of Jihwang-eumja (Dihuang Yizi) compared to Western medications in patients with Alzheimer's disease: A systematic review and meta-analysis

Kim JY, Lee JY, Jung JH, Park YC, Jung IC.

Complement Ther Clin Pract. 2023 May;51:101746. doi: 10.1016/j.ctcp.2023.101746. Epub 2023 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias